AIC
BMY icon

Archer Investment Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Archer Investment Corporation’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Sell
24,272
-46
-0.2% -$2.68K 0.31% 65
2025
Q4 		$1.31M Buy
24,318
+300
+1% +$14.4K 0.3% 69
2025
Q3 		$1.08M Sell
24,018
-654
-3% -$30.5K 0.24% 82
2025
Q2 		$1.14M Buy
24,672
+1
+0% +$49 0.27% 78
2025
Q1 		$1.5M Hold
24,671
– – 0.39% 56
2024
Q4 		$1.4M Sell
24,671
-642
-3% -$35.9K 0.37% 57
2024
Q3 		$1.31M Buy
25,313
+401
+2% +$18.8K 0.35% 61
2024
Q2 		$1.03M Buy
24,912
+2,070
+9% +$92.6K 0.3% 71
2024
Q1 		$1.24M Buy
22,842
+4,080
+22% +$208K 0.37% 59
2023
Q4 		$963K Sell
18,762
-314
-2% -$16.5K 0.31% 71
2023
Q3 		$1.11M Buy
19,076
+1,000
+6% +$61.3K 0.39% 62
2023
Q2 		$1.16M Sell
18,076
-806
-4% -$54K 0.41% 57
2023
Q1 		$1.27M Hold
18,882
– – 0.47% 49
2022
Q4 		$1.36M Sell
18,882
-700
-4% -$52.8K 0.53% 43
2022
Q3 		$1.39M Hold
19,582
– – 0.59% 33
2022
Q2 		$1.51M Hold
19,582
– – 0.61% 31
2022
Q1 		$1.44M Sell
19,582
-1,500
-7% -$101K 0.51% 45
2021
Q4 		$1.31M Buy
21,082
+937
+5% +$55K 0.45% 55
2021
Q3 		$1.19M Buy
20,145
+2,245
+13% +$148K 0.45% 55
2021
Q2 		$1.2M Buy
17,900
+750
+4% +$48.9K 0.47% 46
2021
Q1 		$1.08M Sell
17,150
-1,009
-6% -$62.8K 0.45% 48
2020
Q4 		$1.13M Buy
18,159
+320
+2% +$19.7K 0.54% 43
2020
Q3 		$1.08M Sell
17,839
-255
-1% -$15.3K 0.56% 39
2020
Q2 		$1.06M Buy
18,094
+744
+4% +$44.5K 0.6% 38
2020
Q1 		$967K Buy
17,350
+13,572
+359% +$830K 0.65% 30
2019
Q4 		$243K Buy
3,778
+53
+1% +$3.04K 0.13% 169
2019
Q3 		$189K Hold
3,725
– – 0.11% 171
2019
Q2 		$169K Sell
3,725
-8,400
-69% -$391K 0.11% 176
2019
Q1 		$578K Hold
12,125
– – 0.39% 58
2018
Q4 		$630K Buy
+12,125
New +$651K 0.55% 47

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Archer Investment Corporation's BMY Position: Q1 2026 in Review

Archer Investment Corporation reduced its Bristol-Myers Squibb (BMY) stake by 0.19% in Q1 2026, selling an estimated $2.68K and leaving 24,272 shares worth $1.47M. The position accounts for 0.31% of the portfolio, ranked #65.

Archer Investment Corporation first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.51M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Archer Investment Corporation held 24,272 shares of Bristol-Myers Squibb worth $1.47M as of Q1 2026.
  • Archer Investment Corporation sold 46 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.68K.
  • Bristol-Myers Squibb made up 0.31% of Archer Investment Corporation's portfolio in Q1 2026, its #65 holding.
  • Archer Investment Corporation first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • Archer Investment Corporation's Bristol-Myers Squibb position peaked at $1.51M in Q2 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.